Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Umbilical vein recanalization identified on contrast-enhanced ultrasound in a patient with hepatocellular carcinoma during TACE assessment.

Radiology case reports·2026
Same author

Correction: Scalable flow synthesis of ultrasmall inorganic nanoparticles for biomedical applications via a confined impinging jet mixer.

Scientific reports·2026
Same author

Open-source robotic chip-to-plate interface for high-throughput microfluidic generation of materials libraries.

bioRxiv : the preprint server for biology·2026
Same author

Can nanozymes make the leap to the clinic? Advances, hurdles, and prospects.

Trends in biotechnology·2026
Same author

Comparison of simulated transient elastography sample volumes and global measurements on MRE and MRI-PDFF in patients with suspected MASLD.

Clinical imaging·2026
Same author

Effects of Pressure Cycling, Concentration, and Excitation Amplitude on Ambient Pressure Sensitivity of Perfluorobutane Microbubbles.

Ultrasound in medicine & biology·2026

Related Experiment Video

Updated: Apr 1, 2026

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:40

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

1.2K

Nanoparticle Loaded Polymeric Microbubbles as Contrast Agents for Multimodal Imaging.

Nutte Teraphongphom1, Peter Chhour2,3, John R Eisenbrey4

  • 1School of Biomedical Engineering, Science and Health Systems, Drexel University , Philadelphia, Pennsylvania 19104 United States.

Langmuir : the ACS Journal of Surfaces and Colloids
|October 9, 2015
PubMed
Summary

Researchers developed novel multimodal ultrasound contrast agents using poly(lactic acid) microbubbles. These agents combine ultrasound imaging with fluorescence, MRI, or CT, enhancing diagnostic capabilities and enabling targeted drug delivery.

More Related Videos

Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release
06:02

Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release

Published on: June 12, 2021

4.5K
Synthesis and Characterization of Multi-Modal Phase-Change Porphyrin Droplets
07:59

Synthesis and Characterization of Multi-Modal Phase-Change Porphyrin Droplets

Published on: October 15, 2021

4.1K

Related Experiment Videos

Last Updated: Apr 1, 2026

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers
10:40

Fabricating and Labeling Microbubbles with Fluorescent and Radioactive Tracers

Published on: January 24, 2025

1.2K
Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release
06:02

Multi-timescale Microscopy Methods for the Characterization of Fluorescently-labeled Microbubbles for Ultrasound-Triggered Drug Release

Published on: June 12, 2021

4.5K
Synthesis and Characterization of Multi-Modal Phase-Change Porphyrin Droplets
07:59

Synthesis and Characterization of Multi-Modal Phase-Change Porphyrin Droplets

Published on: October 15, 2021

4.1K

Area of Science:

  • Materials Science
  • Biomedical Engineering
  • Nanotechnology

Background:

  • Ultrasound contrast agents, typically microbubbles (MB) with gas cores stabilized by shells, provide strong echogenicity due to impedance mismatch.
  • Poly(lactic acid) (PLA) microbubbles (MB) demonstrate high echogenicity in vitro and in vivo.
  • Integrating ultrasound (US) with other imaging modalities (fluorescence, MRI, CT) can enhance diagnostic accuracy and information.

Purpose of the Study:

  • To develop multimodal contrast agents by modifying existing PLA MB platforms.
  • To encapsulate various nanoparticles (quantum dots, magnetic iron oxide, gold) within the PLA shell of MB.
  • To create bimodal contrast agents with minimal compromise to individual imaging technique performance.

Main Methods:

  • Modification of pre-existing poly(lactic acid) (PLA) microbubbles (MB).
  • Encapsulation of nanoparticles, including quantum dots (QD), magnetic iron oxide nanoparticles (MNP), and gold nanoparticles (AuNP), into the PLA shell.
  • Evaluation of the performance of the resulting bimodal contrast agents.

Main Results:

  • Successfully created bimodal contrast agents by encapsulating QDs, MNPs, or AuNPs within PLA MB shells.
  • The encapsulation process minimally compromised the performance of individual imaging modalities.
  • Demonstrated the potential for PLA MB to serve as a versatile platform for multimodal imaging.

Conclusions:

  • Poly(lactic acid) microbubbles can be effectively modified to create multimodal contrast agents.
  • Encapsulating nanoparticles like QDs, MNPs, and AuNPs creates versatile platforms for combined imaging.
  • These novel agents offer potential for improved diagnostic accuracy and expanded applications in medical imaging.